ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest ...

Know the key differences, early symptoms, causes and treatment options to avoid confusion and ensure timely medical care in ...

TEER is a minimally invasive procedure that avoids the physical trauma of open-chest surgery. Read more at straitstimes.com.

India is home to nearly 90 million people with T2DM , with an estimated 39.4 million remaining undiagnosed. Recent estimates ...

Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain ...

Esperion (NASDAQ: ESPR) and Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for the treatment of edema associated ...

ANN ARBOR, Mich. and HENDERSON, Nev., March 03, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) and Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing ...

Under the terms of the agreement, Esperion will acquire Corstasis, which developed and is commercializing Enbumyst ™ (bumetanide nasal spray), the first and only nasal spray diuretic approved by the U ...

Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray) – ...

Esperion is a biopharmaceutical company focused on developing and delivering cardiometabolic and rare/orphan disease therapies Corstasis developed Enbumyst, a nasal spray diuretic approved by the US.

A patient fact sheet outlining the differences between heart failure and cardiomyopathy, including subtypes of each condition and diagnostic procedures for both. Cardiomyopathy is a group of heart ...